Counting the Biggest Winners of the $7.2 Billion U.S. Coronavirus Battle
- Federal award to Moderna helps boost biotech firm’s shares
- J&J, 3M, Honeywell also among recipients of U.S. spending
Amsterdam-based Royal Philips NV has so far been the top corporate recipient with some $661.4 million in agreements.
Photographer: Jasper Juinen/Bloomberg
This article is for subscribers only.
Sign up here for our daily coronavirus newsletter on what you need to know, and subscribe to our Covid-19 podcast for the latest news and analysis.
The federal government has awarded $7.2 billion in contracts to fight the coronavirus pandemic, including one that would pay a little-known Massachusetts biotech firm more than its reported revenue for the last three years combined.